Yield10 Bioscience, Inc. Common Stock
YTEN
YTEN was delisted on the 15th of May, 2024.
10 hedge funds and large institutions have $1.05M invested in Yield10 Bioscience, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 3 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
42% more capital invested
Capital invested by funds: $742K → $1.05M (+$311K)
17% less funds holding
Funds holding: 12 → 10 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$34.4K |
| 2 |
Renaissance Technologies
New York
|
+$29.1K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$9.68K |
| 4 |
HDIM
Hanson & Doremus Investment Management
Burlington,
Vermont
|
+$7.53K |
| 5 |
BC
Birchview Capital
Burlington,
Vermont
|
+$2.15K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
GMT Capital
Atlanta,
Georgia
|
-$26K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$10K |
| 3 |
VF
Virtu Financial
New York
|
-$3.23K |
| 4 |
WF
WealthTrust Fairport
Cleveland,
Ohio
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $498K | +$29.1K | +27 | +6% |
|
|
BC
2
Birchview Capital
Burlington,
Vermont
| $141K | +$2.15K | +2 | +2% |
|
|
CC
3
Cannell & Co
New York
| $134K | – | – | – |
|
4
Vanguard Group
Malvern,
Pennsylvania
| $118K | – | – | – |
|
5
Geode Capital Management
Boston,
Massachusetts
| $62K | – | – | – |
|
|
6
Citadel Advisors
Miami,
Florida
| $49K | +$34.4K | +32 | +246% |
|
7
BlackRock
New York
| $17K | – | – | – |
|
|
VF
8
Virtu Financial
New York
| $13K | -$3.23K | -3 | -20% |
|
|
9
UBS Group
Zurich,
Switzerland
| $13K | +$9.68K | +9 | +225% |
|
|
HDIM
10
Hanson & Doremus Investment Management
Burlington,
Vermont
| $8K | +$7.53K | +7 | New |
|
|
APA
11
American Portfolios Advisors
Holbrook,
New York
| $18 | – | – | – |
|
|
GC
12
GMT Capital
Atlanta,
Georgia
| – | -$26K | -32 | Closed |
|
|
TSS
13
Two Sigma Securities
New York
| – | -$10K | -13 | Closed |
|
|
WF
14
WealthTrust Fairport
Cleveland,
Ohio
| – | -$3K | -3 | Closed |
|
YTEN Hedge Fund Activity: Q1 2019 in Review
10 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Yield10 Bioscience, Inc. Common Stock (YTEN) for Q1 2019, worth a combined $1.05M — up 42% from $742K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of YTEN and 1 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 4 added.
The largest buyer was Citadel Advisors, adding an estimated $34.4K. The largest seller was GMT Capital, exiting entirely with an estimated $26K sold.
- 10 institutional investors held Yield10 Bioscience, Inc. Common Stock (YTEN) as of Q1 2019, down from 12 in Q4 2018.
- Funds reported $1.05M of Yield10 Bioscience, Inc. Common Stock stock for Q1 2019, up 42% quarter-over-quarter.
- 1 fund opened new Yield10 Bioscience, Inc. Common Stock positions in Q1 2019 and 3 closed out, a net change of -2 holders.
- The largest Yield10 Bioscience, Inc. Common Stock buyer in Q1 2019 was Citadel Advisors, an estimated $34.4K added.
- The largest Yield10 Bioscience, Inc. Common Stock seller in Q1 2019 was GMT Capital, an estimated $26K sold.
Based on aggregated 13F filings for Q1 2019.